Calan Related Published Studies
Well-designed clinical trials related to Calan (Verapamil)
Alpha-adducin polymorphism associated with increased risk of adverse cardiovascular outcomes: results from GENEtic Substudy of the INternational VErapamil SR-trandolapril STudy (INVEST-GENES). [2008.08]
Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy. [2008.08]
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil. [2007.11]
Blood pressure control and improved cardiovascular outcomes in the International Verapamil SR-Trandolapril Study. [2007.08]
Factors influencing blood pressure response to trandolapril add-on therapy in patients taking verapamil SR (from the International Verapamil SR/Trandolapril [INVEST] Study). [2007.06.01]
Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease. [2007.05]
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. [2007.03.01]
Association of CYP3A5 polymorphisms with hypertension and antihypertensive response to verapamil. [2007.03]
Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial. [2007.03]
Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR. [2007.03]
Validation of the hepatic blood flow rate model for verapamil first-pass metabolism. [2007.01]
Comparison of the effects of nicorandil versus verapamil on the incidence of slow flow/no reflow during rotational atherectomy. [2006.11.15]
Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the INternational VErapamil SR-Trandolapril STudy [INVEST]). [2006.10.01]
Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation. [2006.09.05]
Prospective, randomised, controlled trial to study the effect of intracoronary injection of verapamil and adenosine on coronary blood flow during percutaneous coronary intervention in patients with acute coronary syndromes. [2006.09]
Cardiovascular effects of (R)- and (S)-verapamil and racemic verapamil in humans: a placebo-controlled study. [2006.08]
Effects of clarithromycin and verapamil on rabeprazole pharmacokinetics between CYP2C19 genotypes. [2006.08]
Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: study in healthy volunteers. [2006.04]
Effects of papaverine and glycerilnitrate-verapamil solution as topical and intraluminal vasodilators for internal thoracic artery. [2006.01]
Effect of oral administration of losartan, prazosin, and verapamil on peritoneal solute transport in continuous ambulatory peritoneal dialysis patients. [2005.11]
Comparison of acute and long-term effects of single-dose amiodarone and verapamil for the treatment of immediate recurrences of atrial fibrillation after transthoracic cardioversion. [2005.11]
Assessment of the efficacy of phentolamine to prevent radial artery spasm during cardiac catheterization procedures: a randomized study comparing phentolamine vs. verapamil. [2005.10]
A controlled study on the effect of verapamil on atrial tachycaarrhythmias in patients with brady-tachy syndrome implanted with a DDDR pacemaker. [2005.09.15]
Global differences in blood pressure control and clinical outcomes in the INternational VErapamil SR-Trandolapril STudy (INVEST). [2005.07]
Effect of verapamil on pharmacokinetics and pharmacodynamics of risperidone: in vivo evidence of involvement of P-glycoprotein in risperidone disposition. [2005.07]
Results of the Controlled ONset Verapamil INvestigation of Cardiovascular Endpoints (CONVINCE) trial by geographical region. [2005.05]
Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics. [2005.01]
Well-designed clinical trials possibly related to Calan (Verapamil)
Comparison of rate and rhythm control in hypertension patients with atrial fibrillation. [2008.05]
Reversal of diuretic-associated impaired glucose tolerance and new-onset diabetes: results of the STAR-LET study. [2008.01]
Effect of oral L-type calcium channel blocker on repetitive paroxysmal atrial fibrillation: spectral analysis of fibrillation waves in the Holter monitoring. [2007.12]
Comparative study of nicorandil and a spasmolytic cocktail in preventing radial artery spasm during transradial coronary angiography. [2007.09.03]
Persistent endothelial dysfunction in humans after diesel exhaust inhalation. [2007.08.15]
Corn oil supplementation to steers grazing endophyte-free tall fescue. I. Effects on in vivo digestibility, performance, and carcass traits. [2007.05]
Optimal treatment of obesity-related hypertension: the Hypertension-Obesity-Sibutramine (HOS) study. [2007.04.17]
Prognostic implications of renal dysfunction in patients with stable angina pectoris. [2006.12]
Obesity and insulin resistance but not hyperandrogenism mediates vascular dysfunction in women with polycystic ovary syndrome. [2006.12]
Magnesium sulphate for treatment of severe tetanus: a randomised controlled trial. [2006.10.21]
Rate control and quality of life in patients with permanent atrial fibrillation: the Quality of Life and Atrial Fibrillation (QOLAF) Study. [2006.08]
Prevention of arterial spasm during percutaneous coronary interventions through radial artery: the SPASM study. [2006.08]
Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? [2006.06.20]
Adenosine cardioprotection study in clinical setting of paroxysmal supraventricular tachycardia. [2006.06]
The effect of calcium channel blockers on stone regrowth and recurrence after shock wave lithotripsy. [2006.06]
Depressive symptoms in coronary artery disease patients after hypertension treatment. [2006.04]
Calcitonin gene-related peptide-induced vasodilation in the human forearm is antagonized by CGRP8-37: evaluation of a human in vivo pharmacodynamic model. [2006.03]
Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS). [2006.02]
Phosphodiesterase type 5 inhibition does not reverse endothelial dysfunction in patients with coronary heart disease. [2006.02]
Optimization of myocardial perfusion after primary coronary angioplasty following an acute myocardial infarction. Beyond TIMI 3 flow. [2006.01]
A simple and effective regimen for prevention of radial artery spasm during coronary catheterization. [2006]
Heart rate slowing versus other pharmacological antianginal strategies. [2006]
Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. [2005.12.20]
Effects of the nitric oxide donor, sodium nitroprusside, on resting leg glucose uptake in patients with type 2 diabetes. [2005.12]
Pharmacologic prophylaxis: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. [2005.08]
In vivo performance of controlled release pellets of diltiazem HCl. [2005.04]
Cytochrome P450 enzyme-mediated drug metabolism at exposure to acute hypoxia (corresponding to an altitude of 4,500 m). [2005.03]
Systemic Acyl-CoA:cholesterol acyltransferase inhibition reduces inflammation and improves vascular function in hypercholesterolemia. [2005.02.15]
Effect of magnesium on red blood cell deformability in pregnancy. [2005]
Other research related to Calan (Verapamil)
The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes. [2008.10]
Treatment of pregnant women with a betamimetic and verapamil increases the micronuclei frequency in umbilical cord blood lymphocytes. [2008.08]
Effects of sibutramine plus verapamil sustained release/trandolapril combination on blood pressure and metabolic variables in obese hypertensive patients. [2008.07]
Comparison of intralesional verapamil with intralesional triamcinolone in the treatment of hypertrophic scars and keloids. [2008.07]
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST). [2008.05]
Reduction of enantioselectivity in the kinetic disposition and metabolism of verapamil in rats exposed to toluene. [2008.05]
Dietary salt does not influence the disposition of verapamil enantiomers in relation to efflux transporter ABCB1 genetic polymorphism in healthy Korean subjects. [2008.04]
Enhanced bioavailability of verapamil after oral administration with hesperidin in rats. [2008.04]
Verapamil prevents the apoptotic and hemodynamic changes in response to unilateral ureteral obstruction. [2008.04]
Role of allopurinol, verapamil, dexamethasone and trifluoperazine as prophylactic agents in intestinal ischemia-reperfusion. [2008.04]
Effects of amlodipine, diltiazem, and verapamil on the anticonvulsant action of topiramate against maximal electroshock-induced seizures in mice. [2008.03]
High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. [2008.03]
Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study. [2008.02]
Treatment of experimental verapamil poisoning with levosimendan utilizing a rodent model of drug toxicity. [2008.01]
Effect of Eudragit RS 30D and talc powder on verapamil hydrochloride release from beads coated with drug layered matrices. [2008]
Protective effect of verapamil on gastric hemorrhagic ulcers in severe atherosclerotic rats. [2007.12.31]
Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. [2007.12.19]
[Effects of Verapamil and Metoprolol on heart rate variability in patients with coronary heart disease.] [2007.12.18]
[A 48-year-old woman's survival from a massive verapamil overdose] [2007.11.19]
The protective effects of intravenous anesthetics and verapamil in gut ischemia/reperfusion-induced liver injury. [2007.11]
Extracorporeal life support in severe propranolol and verapamil intoxication. [2007.11]
Effects of normothermic organ bath and verapamil-nitroglycerin solution alone or in combination on the blood flow of radial artery. [2007.10]
Verapamil-induced erythermalgia. [2007.10]
Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil. [2007.09]
[Verapamil effect and influence on postoperative epidural analgesia and cell factors TNFalpha, IL-6 and IL-2] [2007.09]
Hyperinsulinemic euglycemia therapy for verapamil poisoning: case report. [2007.09]
KCNMB1 genotype influences response to verapamil SR and adverse outcomes in the INternational VErapamil SR/Trandolapril STudy (INVEST). [2007.09]
Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. [2007.08.14]
[Protective effect of verapamil pretreatment against cerebral ischemia-reperfusion injury in gerbils.] [2007.07]
Calcium antagonist verapamil and reperfusion injury of the heart. [2007.06]
Verapamil for ventricular tachycardia. [2007.06]
Zinc ions efflux from lymphocytes in vitro in the presence of a calcium and magnesium ionic environment and its changes following administration of verapamil. [2007.06]
Reversing adriamycin resistance of human breast cancer cells by hyperthermia combined with Interferon alpha and Verapamil. [2007.06]
Augmentation of cerebral blood flow and reversal of endothelin-1-induced vasospasm: a comparison of intracarotid nicardipine and verapamil. [2007.04]
Topical verapamil HCl, topical trifluoperazine, and topical magnesium sulfate for the treatment of Peyronie's disease--a placebo-controlled pilot study. [2007.03]
Hemodynamic effects of intravenous fat emulsion in an animal model of severe verapamil toxicity resuscitated with atropine, calcium, and saline. [2007.02]
Effect of verapamil on urinary stone-forming risk factors. [2007.02]
Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells. [2007.01]
Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil. [2007]
Managing hypertension in diabetic patients--focus on trandolapril/verapamil combination. [2007]
Trandolapril/verapamil combination in hypertensive diabetic patients. [2007]
Effect of verapamil on urinary stone-forming risk factors. [2006.12.13]
Evaluation of rate of swelling and erosion of verapamil (VRP) sustained-release matrix tablets. [2006.11]
Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. [2006.10.12]
Efficacy of a fixed-dose combination of trandolapril-verapamil in obese hypertensive patients resistant to monotherapy. [2006.10]
|
